Big pharma’s monopoly in the Covid-19 pandemic

SHARE

Access to preventative medication comes with several conditions, most often left in the hands of multinational pharmaceutical companies; all in the name of profit.

With the global rush to vaccinate against Covid-19, amidst the presence of the Omicron variant, these doses are in short supply. This as the developing world is at the mercy of pharmaceutical corporations and Western governments that are allowing their monopoly to continue.

Guest: Achal Prabhala – Coordinator, AccessIBSA project


More Posts for Show: NRA

Featured

News Headlines

Instability at the Student Financial Aid Scheme (NSFAS) continues. Higher Education Minister Blade Nzimande has…
Scroll to Top